Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2005
11/03/2005US20050244840 Method of screening anti-mycobacterial molecules
11/03/2005US20050244832 Class II cytokine receptor-7
11/03/2005US20050244828 Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244816 Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics
11/03/2005US20050244425 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244416 Bispecific antibody molecule
11/03/2005US20050244415 administering an antibody which recognizes an extracellular domain of signal regulatory protein-beta (SIRP-beta); treatment of infections or cancer
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244411 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
11/03/2005US20050244410 Toll-like receptor 9 effector agents and uses thereof
11/03/2005US20050244409 Erythropoietin receptor antibodies
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244407 Therapeutic synergy of anti-cancer compounds
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244403 Diagnosis and therapy, antibody variant
11/03/2005US20050244371 Treating cancer using ultrapheresis; tissue necrosis factor receptor-2 (TNFR-2);
11/03/2005US20050244333 That combine a binding site recognizing the same epitope as T84.66 and a polypeptide framework of a human or humanized antibody; exhibit binding affinity and specificity for carcinoembryonic antigen nearly identical to that of T84.66 and the ability to specifically target tumors expressing CEA
11/03/2005CA2567748A1 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
11/03/2005CA2564137A1 Treatment of fungal infections
11/03/2005CA2562764A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
11/03/2005CA2561706A1 Truncated adamts molecules
11/03/2005CA2561065A1 Therapeutic use of anti-cs1 antibodies
11/03/2005CA2555185A1 Anti-cd38 human antibodies and uses therefor
11/02/2005EP1591791A2 Diagnostic assay for human matrix gla-protein and its use as a biomarker
11/02/2005EP1591790A2 Method and reagents for determining protein S.
11/02/2005EP1591537A2 Hereditary hemochromatosis gene
11/02/2005EP1591530A2 A tumor necrosis factor related ligand
11/02/2005EP1591529A2 Human CLTA-8 and uses of CTLA-8-related proteins
11/02/2005EP1591527A1 Substance specific to human pd-1
11/02/2005EP1591526A2 Frazzled nucleotide sequences, expression products, compositions and uses
11/02/2005EP1591456A1 Antibodies for cancer therapy and diagnosis
11/02/2005EP1591452A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2005EP1591128A1 Thymosin beta 4 promotes wound repair
11/02/2005EP1590480A2 Novel proteins and nucleic acids encoding same
11/02/2005EP1590440A2 Cell-killing molecules and methods of use thereof
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590431A2 TNF-a BINDING MOLECULES
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590371A2 Immunoglobulin
11/02/2005EP1590370A1 Increase of the immune response by substances influencing the function of natural killer cells
11/02/2005EP1590369A2 Human il-1 beta antagonists
11/02/2005EP1590368A1 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
11/02/2005EP1590365A2 Mycobacterial diagnostics
11/02/2005EP1590364A2 Human monoclonal antibodies against interleukin 8 (il-8)
11/02/2005EP1589998A2 Uses of mammalian cytokine; related reagents
11/02/2005EP1589997A2 Identification of cellular polypeptides differentially expressed by tumor cells
11/02/2005EP1589996A2 Anti-integrin alpha beta 3 antibody formulat ions and uses thereof
11/02/2005EP1589995A1 Use of avian antibodies
11/02/2005EP1589994A2 Composition and method for preventing or treating a virus infection
11/02/2005EP1589985A2 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620
11/02/2005EP1589981A2 Interferon antagonists useful for the treatment of interferon related diseases
11/02/2005EP1589933A2 Compositions and methods for the diagnosis and treatment of tumor
11/02/2005EP1416965A4 Assay method for alzheimer's disease
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1200123B1 Diagnosis and treatment of neuroectodermal tumors
11/02/2005EP1187845B1 Tumor suppressor molecules and methods of use
11/02/2005EP1183355B1 T-bet compositions and methods of use thereof
11/02/2005EP1141237B1 Pth receptor and screening assay utilizing the same
11/02/2005EP1005488B1 Receptor that binds trail
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005EP0601135B1 Osteogenic proteins in the treatment of metabolic bone diseases
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691963A Treatment of tnfalpha related disorders
11/02/2005CN1691958A Enos mutants useful for gene therapy
11/02/2005CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2005CN1689646A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1689645A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1689644A Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/02/2005CN1225555C Human TOLL-like receptor proteins, related reagents and methods
11/02/2005CN1225480C Anti CD52 monoclonal antibody, coding sequence and use thereof
11/02/2005CN1225479C Tumour necrosis factor antibody, preparing method and medicinal composition thereof
11/02/2005CN1225478C Embedded CD25-resisting monoclonal antibody and its coding sequence and application
11/02/2005CN1225475C Candida albicans molecular companion gene and its use
11/01/2005US6960653 Method and kit for detecting, or determining the quantity of, beta-lactam penicillins
11/01/2005US6960652 Used to produce immunotoxins (ITs) and cytokines with a reduced ability to promote vascular leak syndrome (VLS)
11/01/2005US6960650 Nucleotide sequences coding proteins for use in the treatment of tumors
11/01/2005US6960570 Compositions and methods for the therapy and diagnosis of lung cancer
11/01/2005US6960559 Neurite growth regulatory factors
11/01/2005US6960472 Monoclonal antibodies against N-Terminus proBNP
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960446 Nucleotide sequences coding enzymatic polypeptide; for use in bone marrow therapy
11/01/2005US6960443 Anticancer, antitumor agents; monoclonal antibodies; genetic engineered protein
11/01/2005US6960442 Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
11/01/2005US6960440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/01/2005US6960430 Screening methods for compounds useful in the regulation of cell proliferation
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005CA2294078C C-peptide specific assay procedure
10/2005
10/27/2005WO2005101017A1 Mass spectrometry of antibody conjugates
10/27/2005WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product
10/27/2005WO2005100566A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005WO2005100560A1 Cell death inducer
1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 1494